Table 2.
Clinical characteristics and outcomes in intervention group and control group patients
| Intervention group | Control group | T-value | Sig. | |
|---|---|---|---|---|
| Mean (S.D.) | Mean (S.D.) | |||
| General overuse | 12.42 (2.24) | 12.74 (2.63) | 0.966 | 0.335 |
| General harm | 11.16 (2.50) | 10.88 (2.96) | 0.763 | 0.446 |
| Beneficial effect of pharmaceuticals | 14.69 (1.97) | 14.96 (2.14) | 0.984 | 0.326 |
| Beliefs about medicines | 38.27 (3.92) | 38.58 (4.48) | 0.545 | 0.587 |
| Sensitive | 15.72 (2.66) | 15.55 (3.13) | 0.441 | 0.660 |
| Necessity beliefs | 18.19 (3.68) | 18.30 (4.19) | 0.205 | 0.838 |
| Concern beliefs | 13.07 (3.36) | 13.38 (4.04) | 0.616 | 0.538 |
| Treatment Satisfaction Questionnaire for Medication (TSQM) | 83.20 (11.42) | 82.54 (13.41) | 0.396 | 0.692 |
| Estimated weights for EQ-5D | 0.63 (0.37) | 0.65 (0.38) | 0.414 | 0.680 |
| Montgomery–Åsberg Depression Scale | 22.90 (13.27) | 21.44 (12.89) | 0.830 | 0.408 |
| Medication Adherence Scale | 5.13 (1.80) | 5.19 (2.05) | 0.218 | 0.827 |
T-test for the difference in the characteristics of the study, according to the level of adherence